Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.52M Sell
26,281
-20,874
-44% -$7.15M 2.06% 22
2026
Q1
$16.6M Sell
47,155
-13,801
-23% -$4.92M 3.92% 6
2025
Q4
$20M Sell
60,956
-500
-0.8% -$159K 4.55% 8
2025
Q3
$17.3M Buy
61,456
+17,456
+40% +$5.06M 4.3% 8
2025
Q2
$12.3M Sell
44,000
-15,000
-25% -$4.25M 4.02% 8
2025
Q1
$18.4M Buy
59,000
+13,000
+28% +$3.84M 5.89% 5
2024
Q4
$12M Buy
46,000
+30,000
+188% +$8.9M 4.12% 9
2024
Q3
$5.16M Sell
16,000
-14,000
-47% -$4.58M 1.56% 21
2024
Q2
$9.37M Buy
+30,000
New +$8.81M 3.5% 10

Other funds holding AMGN

Sector Gamma AS's AMGN Position: Q2 2026 in Review

Sector Gamma AS reduced its Amgen (AMGN) stake by 44% in Q2 2026, selling an estimated $7.15M and leaving 26,281 shares worth $9.52M. The position accounts for 2.06% of the portfolio, ranked #22.

Sector Gamma AS first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $20M in Q4 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sector Gamma AS held 26,281 shares of Amgen worth $9.52M as of Q2 2026.
  • Sector Gamma AS sold 20,874 Amgen shares in Q2 2026, an estimated $7.15M.
  • Amgen made up 2.06% of Sector Gamma AS's portfolio in Q2 2026, its #22 holding.
  • Sector Gamma AS first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • Sector Gamma AS's Amgen position peaked at $20M in Q4 2025.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.